Attenuated fowl pox virus preparation for the treatment of infectious diseases, method for the manufacture thereof, and its use
Patent 4053582 Issued on October 11, 1977. Estimated Expiration Date: 
October 11, 1994. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
October 11, 1994. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References3429965 InventorApplicationNo. 05/599533 filed on 07/28/1975US Classes:424/281.1, Virus (e.g., interferon-inducing virus, etc.)435/237, By serial passage of virus435/811, INTERFERON514/889INTERFERON INDUCERExaminersPrimary: Rosen, SamAttorney, Agent or FirmForeign Application Priority Data1974-08-01 DTAbstractPreparation for the treatment of interferon-sensitive infectious diseases for use in human and veterinary medicine, characterized by the fact that it contains as active principle a fowl pox virus which has been attenuated by 420 to 800 cell culture passages, optionally together with a pharmaceutical excipient or adjuvant, preferably containing a sufficient number of virus units so as to provide a total of 108 to 1010 virus units per treatment involving 2 to 6 administrations thereof, method for the production thereof, method of producing pharmaceutical forms thereof, the pharmaceutical forms themselves, and a method of growing an effective fowl pox virus for use in the preparations of the invention.Other References
|
| ||||||||||||||
